General Pharmacology: The Vascular System 1993-01-01

Des-tyrosine-gamma-endorphin effects on morphine analgesia in mice.

S Pieretti, A Di Giannuario, A Loizzo

Index: Gen. Pharmacol. 24(1) , 83-8, (1993)

Full Text: HTML

Abstract

1. The effects that were induced by a beta-lipotropin fragment des-tyrosine-gamma-endorphin (DT gamma E) devoid of opiate activity that was administered intraperitoneally or intracerebroventricularly to mice under morphine analgesia were investigated. The interaction of this peptide with the analgesic effects of morphine was examined using the hot plate and the tail flick test. 2. Intraperitoneal acute treatment with DT gamma E did not change the analgesic effects of morphine. 3. Intraperitoneal semi-chronic treatment performed for 4 days with DT gamma E enhanced morphine analgesic effects. 4. The intracerebroventricular acute treatment with DT gamma E reduced morphine analgesia in a dose-dependent way. 5. These results indicate that DT gamma E, although devoid of opioid activity per se, may interact with the opioid system, probably through an indirect mechanism.

Related Compounds

  • [Des-Tyr1] g-Endo...

Related Articles:

Interaction between des-Tyr1-gamma-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtype.

1985-01-01

[Immunogenetics 22(4) , 309-14, (1985)]

Short-lived effect of (Des-Tyr)-gamma-endorphin in schizophrenia.

1983-12-01

[Psychiatry Res. 10(4) , 243-52, (1983)]

Subchronic treatment with fragments of beta-endorphin prevents electroencephalographic seizures and behavioral alterations induced by centrally administered beta-endorphin in the rabbit.

1994-02-01

[J. Pharmacol. Exp. Ther. 268(2) , 1040-50, (1994)]

Criteria for evaluating improvement in schizophrenia in psychopharmacological research (with special reference to gamma endorphin fragments).

1988-09-01

[Br. J. Psychiatry 153 , 354-8, (1988)]

A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.

1986-10-01

[Int. Clin. Psychopharmacol. 1(4) , 303-13, (1986)]

More Articles...